CHAMPIONS ONCOLOGY, INC. Shareholders' Equity
CHAMPIONS ONCOLOGY, INC. (CSBR) had Shareholders' Equity of $3.89 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-09-11
- 2026-07-31: Stockholders' Equity Attributable to Parent $3.89M.
- 2026-04-30: Stockholders' Equity Attributable to Parent $3.94M.
- 2026-01-31: Stockholders' Equity Attributable to Parent $4.28M.
- 2025-10-31: Stockholders' Equity Attributable to Parent $4.17M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-07-31 | $3.89M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $3.94M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $4.28M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $4.17M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $3.51M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $3.77M 10-K · filed 2026-07-27 | |
| 2025-01-31 | $5.47M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $681.00K 10-Q · filed 2025-03-17 | |
| 2024-07-31 | -$332.00K 10-Q · filed 2025-03-17 | |
| 2024-04-30 | -$1.90M 10-K · filed 2025-07-23 | |
| 2024-01-31 | -$2.06M 10-Q · filed 2025-03-17 | |
| 2023-10-31 | $93.00K 10-Q · filed 2025-03-17 | |
| 2023-07-31 | $1.90M 10-Q · filed 2025-03-17 | |
| 2023-04-30 | $4.64M 10-K · filed 2025-07-23 | |
| 2023-01-31 | $7.06M 10-Q · filed 2024-03-15 | |
| 2022-10-31 | $9.17M 10-Q · filed 2024-03-15 | |
| 2022-07-31 | $8.98M 10-Q · filed 2024-03-15 | |
| 2022-04-30 | $9.10M 10-K · filed 2024-07-19 | |
| 2022-01-31 | $9.24M 10-Q · filed 2023-03-16 | |
| 2021-10-31 | $8.07M 10-Q · filed 2023-03-16 | |
| 2021-07-31 | $7.54M 10-Q · filed 2023-03-16 | |
| 2021-04-30 | $7.43M 10-K · filed 2023-07-24 | |
| 2021-01-31 | $8.09M 10-Q · filed 2022-03-15 | $7.87M 10-Q · filed 2021-03-15 |
| 2020-10-31 | $6.89M 10-Q · filed 2022-03-15 | |
| 2020-07-31 | $5.51M 10-Q · filed 2022-03-15 | |
| 2020-04-30 | $5.10M 10-K · filed 2022-07-22 | $5.32M 10-K · filed 2020-07-28 |
| 2020-01-31 | $5.51M 10-Q · filed 2021-09-13 | $3.18M 10-Q · filed 2020-03-16 |
| 2019-10-31 | $2.11M 10-Q · filed 2021-03-15 | |
| 2019-07-31 | $1.73M 10-Q · filed 2021-03-15 | |
| 2019-04-30 | $2.14M 10-K · filed 2021-07-26 | $2.24M 10-K · filed 2019-07-29 |
| 2019-01-31 | $2.32M 10-Q · filed 2020-03-16 | |
| 2018-10-31 | $1.99M 10-Q · filed 2020-03-16 | |
| 2018-07-31 | $603.00K 10-Q · filed 2020-03-16 | $602.00K 10-Q · filed 2018-09-14 |
| 2018-04-30 | $3.00K 10-K · filed 2020-07-28 | |
| 2018-01-31 | $472.00K 10-Q · filed 2018-03-19 | |
| 2017-10-31 | $373.00K 10-Q · filed 2017-12-15 | |
| 2017-07-31 | $290.00K 10-Q · filed 2017-09-14 | |
| 2017-04-30 | $400.00K 10-K · filed 2019-07-29 | |
| 2017-01-31 | $2.04M 10-Q · filed 2017-03-17 | |
| 2016-10-31 | $3.21M 10-Q · filed 2016-12-14 | |
| 2016-07-31 | $3.18M 10-Q · filed 2016-09-14 | |
| 2016-04-30 | $238.00K 10-K · filed 2018-07-30 | |
| 2016-01-31 | $2.26M 10-Q · filed 2016-03-16 | |
| 2015-10-31 | $4.10M 10-Q · filed 2015-12-15 | |
| 2015-07-31 | $5.90M 10-Q · filed 2015-09-11 | |
| 2015-04-30 | $8.06M 10-K · filed 2017-07-28 | |
| 2015-01-31 | -$4.14M 10-Q · filed 2015-03-17 | |
| 2014-10-31 | -$1.86M 10-Q · filed 2014-12-15 | |
| 2014-07-31 | $439.00K 10-Q · filed 2014-09-12 | |
| 2014-04-30 | $3.20M 10-K · filed 2016-07-29 | |
| 2014-01-31 | $4.49M 10-Q · filed 2014-03-14 | |
| 2013-10-31 | -$12.74M 10-Q · filed 2013-12-13 | |
| 2013-07-31 | -$10.89M 10-Q · filed 2013-09-13 | |
| 2013-04-30 | -$9.21M 10-K · filed 2015-07-29 | |
| 2013-01-31 | -$7.60M 10-Q · filed 2013-03-13 | |
| 2012-10-31 | -$7.18M 10-Q · filed 2012-12-13 | |
| 2012-07-31 | -$5.84M 10-Q · filed 2012-09-12 | |
| 2012-04-30 | -$5.28M 10-K · filed 2014-07-28 | |
| 2012-01-31 | -$3.38M 10-Q · filed 2012-03-14 | |
| 2011-10-31 | -$2.39M 10-Q · filed 2011-12-14 | |
| 2011-07-31 | -$992.00K 10-Q · filed 2011-09-13 | |
| 2011-04-30 | $19.00K 10-K · filed 2013-07-26 | |
| 2010-04-30 | $1.58M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |